(-)-Epigallocatechin Gallate

製品コードS2250 別名:EGCG

(-)-Epigallocatechin Gallate化学構造

分子量(MW):458.37

(-)-Epigallocatechin Gallate(EGCG) is the main catechin extraction of green tea that inhibits telomerase and DNA methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors. ECGG inhibits fatty acid synthase and glutamate dehydrogenase activity.

サイズ 価格(税別)  
JPY 26560.00
JPY 8300.00
JPY 11620.00

カスタマーフィードバック(4)

  • (a) Huh7 cells were incubated with HCVcc of JFH-1 for 2 h before overlaying with 1% agarose dissolved in culture medium or with AR3A anti-E2 neutralizing antibodies, in the presence of 20 μg/ml SZA. EGCG (50 μM) was introduced as a positive control. At 48 h post-infection, infected cells were quantified by IF. Nuclei were stained with DAPI. (b) Numbers of cells per positive colony were determined in 15 foci.

    Sci Rep, 2016, 6:27268.. (-)-Epigallocatechin Gallate purchased from Selleck.

    EGCG treatment increases cTnI protein levels in ageing hearts. (A) Western blotting analysis using cTnI and cTnT antibodies. b-Actin was used as protein loading control. (B) A summary of Western blotting results of cTnI. Values are expressed as mean S.D. from four separate experiments. Statistical significance was determined by ANOVA followed by least significant difference (LSD) tests. *P < 0.05 as compared with the 18M + EGCG and 3M groups. EGCG: epigallocatechin-3-gallate

    J Cell Mol Med, 2017, 21(10):2481-2490. (-)-Epigallocatechin Gallate purchased from Selleck.

  • PLoS One 2013 8(8), e69519. (-)-Epigallocatechin Gallate purchased from Selleck.

    PLoS One 2013 8(8), e69519. (-)-Epigallocatechin Gallate purchased from Selleck.

製品安全説明書

Telomerase阻害剤の選択性比較

生物活性

製品説明 (-)-Epigallocatechin Gallate(EGCG) is the main catechin extraction of green tea that inhibits telomerase and DNA methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors. ECGG inhibits fatty acid synthase and glutamate dehydrogenase activity.
体外試験

(-)-Epigallocatechin gallate functions as a powerful antioxidant, preventing oxidative damage in healthy cells, but also as an antiangiogenic and antitumor agent and as a modulator of tumor cell response to chemotherapy. (-)-Epigallocatechin gallate shows multiple anticancer effects, such as anti-proliferation, anti-angiogenesis, transformation prevention of various cancer cells, cancer cell cycle arrest and inhibition of tumor metastasis. (-)-Epigallocatechin gallate exerts multi-anticancer effects through regulating several cancer-related cell signal pathways (regulated the function or the expression of key signal proteins, such as nuclear factor-κB, MAPKs and activator protein-1, EGFR, IGF, COX-2 signaling pathway, and so on.), effecting methylation of cancer genes and combination of ligand with membrane receptors. [1] (-)-Epigallocatechin gallate also shows an immunomodulating effects. Several types of immune cells in both the innate and adaptive immune systems are known to be affected in varying degrees by (-)-Epigallocatechin gallate. Among them, the dramatic effect on T cell functions has been repeatedly demonstrated, including T cell activation, proliferation, differentiation, and production of cytokines. Studies using animal models of autoimmune diseases have reported disease improvement in animals treated with green tea/EGCG. [2] (-)-Epigallocatechin gallate displays anti-infective properties. Antiviral activities of (-)-Epigallocatechin gallate with different modes of action have been demonstrated on diverse families of viruses, such as Retroviridae, Orthomyxoviridae and Flaviviridae and include important human pathogens like human immunodeficiency virus, influenza A virus and the hepatitis C virus. [3]

細胞データ
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SH-SY5Y cells NIjkT3BHfW6ldHnvckBie3OjeR?= M2W0OW5mfXKxcILveIVkfGmxbjDh[4FqdnO2IHLleIEu[W27bH;p[EBx\XC2aXTlJFEuPDJvaX7keYNm\CC2b4jpZ4l1gSCrbjDoeY1idiCVSD3TXVV[KGOnbHzzJIF{e2W|c3XkJIF{KGyjY4TheIUh\GWqeXTyc4dmdmG|ZTDy[Yxm[XOnLDDFR|UxRTBwMEO5PFch|ryP MkO5NVkyOzh6NUm=
human MDA435/LCC6MDR cells Mn:xSpVv[3Srb36gZZN{[Xl? MXexNEDPxE1? NHL5ZZk2KGSjeYO= MVXNc4R2dGG2aX;uJI9nKFBvZ4CgLJVvc26xd36gc5Jq\2mwKTD0doFve2[nY4Tl[EBqdiCqdX3hckBOTEF2M{WvUGNEPk2GUjDj[YxteyCjc4Pld5Nm\CCjczDy[ZZmenOrYnzlJI9nKHCjY3zpeIF5\WxicnXzbZN1[W6lZTDt[YF{fXKnZDDhd{BKSzVyIH\vdkBx[WOuaYThfIVtKGG2IEGwJJVOKGGodHXyJFUh\GG7czDifUBE\WyuVHn0[ZIhQTZiQYH1[Y92eyCjc4PhfUwhUUN3ME2wMlEzOjZizszN M{G2flI2QTh3MUm1
Sf9 cells MkfqSpVv[3Srb36gZZN{[Xl? NGnvSHdKdmirYnn0bY9vKG:oIFjpd|YufGGpZ3XkJIh2dWGwIILlZ49u[mmwYX70JGRPVVRzIHX4dJJme3OnZDDpckBqdnOnY4SgV4Y6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDEUmEhdWW2aInseJJidnOoZYLhd4Uh[WO2aY\peJkhfXOrbnegOUcu[mmxdHnufYxifGWmIES1MYJxKHWwbXX0bJlt[XSnZDDvdkBp\W2rbXX0bJlt[XSnZDDvcIlod263Y3zlc5Rq\GVic4Xid5Rz[XSnczDhcoQhYzOKXT3B[I9O\XRiYomgcIlyfWmmIIPjbY51cWyuYYTpc44h[2:3boTpcochdWW2aH;kMEBKSzVyPUCuOUDPxE1? MVeyOVQxPjl2NB?=
human U937 cells M3zQVGZ2dmO2aX;uJIF{e2G7 M4fmeWlvcGmkaYTpc44hd2ZidHXsc41memG|ZTDpckBpfW2jbjDVPVM4KGOnbHzzMEBKSzVyPUGg{txO NF3lenQzOjRzM{i0OS=>
human HeLa cells NIL6WJpHfW6ldHnvckBie3OjeR?= M3LIWGlvcGmkaYTpc44hd2ZidHXsc41memG|ZTDpckBpfW2jbjDI[WxiKGOnbHzzJJV{cW6pIEWnMWFCXCCFQ1egWGNIKEGJQzDBS2EhT1SWLUOnJIF{KHO3YoP0doF1\SCrbnP1ZoF1\WRiZn;yJFE2KG2rboOgdJJqd3JidH:g[Zh1\W6|aX;uJJJm[WO2aX;uJIZwdGyxd3XkJIJ6KGOxbYDveY5lKHejc3jveZQh[nlic4Dpck11\WyxbXXybYMhemWyZXH0JIFueGyrZnnjZZRqd25icILveI9kd2xuIFnDOVA:OS5yODFOwG0> M1z6TFIzPDF|OES1
CHO cells NVi2dGc5S3m2b4TvfIlkyqCjc4PhfS=> NGnudGw1QCCq NXT3b2kzS3m2b4TvfIlkcXS7IHHnZYlve3RiQ1jPJINmdGy|IHX4dJJme3OrbnegU2FVWDGEMzDoZZBtd3S7cHWgNUBi\nSncjC0PEBpenNiYomg[ox2d3Knc3PlcoNmKGKjc3XkJGNmdGyWaYTldk1IdG9iYYPzZZktKEmFNUC9N{4zKM7:TR?= NU\EXmt3OjN|Mke4O|c>
MDCK cells MlTESpVv[3Srb36gZZN{[Xl? MXW0JIRigXN? MX3BcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDpcoZtfWWwenGgRUB3cXK3czCoRU9{f2mwZT;PTE82OTF2NEWvNlAxPyiKMV6xLUkhV2h5IHnu[oVkfGWmIHnuJG1FS0tiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kB3cXKjbDDy[ZBtcWOjdHnvckBi\nSncjC0JIRigXNiYomgdZVidnSrdHH0bZZmKFKWLWDDVkwhTUR3ME24MlMh|ryP Mk[xNlIyOTV3OUG=
human HL60 cells M4SyR3Bzd2yrZnXyZZRqd25iYYPzZZk> MVmzJIRigXN? MnLWRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKTE[wJINmdGy|IHHmeIVzKDNiZHH5d{whUUN3ME25MlQh|ryP NGizVVIyQDZ7M{CyNC=>
HSC-T6 cells  MlLlSpVv[3Srb36gZZN{[Xl? NFP2Zng1QCCq MmDhRY51cW[rYoLveIlkKGGldHn2bZR6KGGpYXnud5QhemG2IFjTR{1VPiClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJBzd2yrZnXyZZRqd25iYX\0[ZIhPDhiaILzJIJ6KEK{ZGWgbY5kd3Kyb4LheIlwdiCjc4PhfUwhUUN3ME25Mlkh|ryP MlPvNlE2ODR6NEi=
mouse 3T3-L1 cells NYDNXlZ2TnWwY4Tpc44h[XO|YYm= NHnITo9KdmirYnn0bY9vKG:oIFe2VGQudWWmaXH0[YQhVkGGUFigdJJw\HWldHnvckBqdiCvb4Xz[UA{XDNvTEGgZ4VtdHNuIFnDOVA:OjVizszN M1HhN|E5OzF|M{C4
mouse RAW264.7 cells NV70bVVJTnWwY4Tpc44h[XO|YYm= M4X3UlUh\GG7cx?= MYfJcohq[mm2aX;uJI9nKFKDTlvMMYlv\HWlZXSgc5N1\W:lbHHzeI9o\W6nc3nzJIlvKG2xdYPlJHJCXzJ4ND63JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKFSUQWCtdI9{cXSrdnWgcZVtfGlvboXjcIVifGWmIHPlcIx{KGGodHXyJFUh\GG7czygTWM2OD1{OT64JO69VQ>? NWTY[W9mOjF2NU[1NlE>
HSC-T6 cells MlS4VJJwdGmoZYLheIlwdiCjc4PhfS=> M{Hyc2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgdoF1KEiVQz3UOkBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iY3XscEB3cWGkaXzpeJktKEmFNUC9NlkvQCEQvF2= NIHib4ozPTN{MkS1OS=>
human A431 cells Mlf5VJJwdGmoZYLheIlwdiCjc4PhfS=> NGK5eWs1QCCq MX\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF2M{GgZ4VtdHNib4\ldoV5eHKnc4PpcochTXKkQjDpckB{\XK3bT3mdoVmKG2nZHn1cUBie3Onc4Pl[EBieyClZXzsJJZq[WKrbHn0fUBi\nSncjC0PEBpenNiYomgW3NVNTFiYYPzZZktKEWFNUC9N|gh|ryP MnOxNlQ1PTZyMES=
human MDA-MB-231 cells MXPQdo9tcW[ncnH0bY9vKGG|c3H5 Mn23NlQhcA>? MUXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfS=> MnvxNlI1PTl{MEi=
human HepG2 cells NHHHbY5HfW6ldHnvckBie3OjeR?= MVqyOEBp M{KyTWlvcGmkaYTpc44hd2Zib3zlbYMh[WOrZD3pcoR2[2WmIITybYdtgWOncnnk[UBwfmW{LXHjZ5VufWyjdHnvckBqdiCqdX3hckBJ\XCJMjDj[YxteyCrbnP1ZoF1\WRiZn;yJFI1KGi{czDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> NFq1Z5czOTh{NE[5NC=>
human HepG2 cells MXvGeY5kfGmxbjDhd5NigQ>? MWOyOEBp NY\kXYh6SW62aX;4bYRidnRiYXP0bZZqfHliaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKG:oIH;s[YlkKGGlaXStbY5lfWOnZDDSU3Mh\2WwZYLheIlwdiCrbnP1ZoF1\WRiZn;yJFI1KGi{czDifUBFUEOILVTBJIJie2WmIH\seY9zcW2ndILpZ{Bie3OjeTDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> MVOyNVgzPDZ7MB?=
human Caco-2 cells NUDUfo1PT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NVrHRXRvOjVizszN MWi2JIRigXN? M3zkfWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJGNi[29vMjDj[YxteyCjdDCyOUB2VSCjZoTldkA3KGSjeYO= NWC4cVBwOTh|MkS3OlM>
mouse 3T3 cells Mnn2SpVv[3Srb36gZZN{[Xl? NIfQSY8yNTJyIN88US=> MYKxNkBp M1rwUmFvfGmvaXfyZZRwenliYXP0bZZqfHliYXfhbY5{fCCVd3nzd{BidGKrbn:gcY92e2ViM2SzJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKGOnbHygcpVu[mW{czDheEAyKHSxIEKwJJVOKGGodHXyJFEzKGi{czDifUBjgSC|Y4LheINpNXexdX7kJIF{e2G7 MXuyNVA5ODZ2Mh?=
human MDA-MB-231 cells NV7oSpVvWHKxbHnm[ZJifGmxbjDhd5NigQ>? M4D4clI1KGh? NUHzN|QySW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[Xl? NVzTWGVyOjJ2NUmyNFg>
human Jurkat cells Ml7MSpVv[3Srb36gZZN{[Xl? NXL3bZBoOTBvNUWg{txO NWf6NZdROjRiaB?= M2\MXGlvcGmkaYTpc44hd2ZiVF7GZYxxcGFvaX7keYNm\CCQRj3rZZBx[UJiYXP0bZZifGmxbjDpckBpfW2jbjDKeZJs[XRiY3XscJMh[XRiMUCgeI8hPTVidV2gZYZ1\XJiMkSgbJJ{KGK7IHXs[YN1em:yaH;y[ZRq[yCvb3LpcIl1gSC|aHnmeEBie3OjeR?= NFrCc5YzOTB6ME[0Ni=>
human K562 cells NXP2Z|A4TnWwY4Tpc44h[XO|YYm= MWqyOEBp NYXHbGozUW6mdXP0bY9vKG:oIE[3JItF[SCuYX3pcolvKHKnY3XweI9zKGW6cILld5Nqd25iaX6gbJVu[W5iS{W2NkBk\WyuczDh[pRmeiB{NDDodpMh[nliZnzve{BkgXSxbXX0dpkh[W6jbInzbZM> MVOyNVQ{PDZyMx?=
human HL60 cells NVK0Nm41TnWwY4Tpc44h[XO|YYm= NVnETY9IOjRiaB?= MWDJcoR2[3Srb36gc4YhPjdia1ThJIxidWmwaX6gdoVk\XC2b4Kg[ZhxemW|c3nvckBqdiCqdX3hckBJVDZyIHPlcIx{KGGodHXyJFI1KGi{czDifUBndG:5IHP5eI9u\XS{eTDhcoFtgXOrcx?= M4Lid|IyPDN2NkCz
human Raji cells NXfBOVVRT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M1XWSVExKM7:TR?= NWfD[IZxPDhiaB?= MmDyS5Jwf3SqIHnubIljcXSrb36gZYdicW6|dDDoeY1idiCUYXrpJINmdGy|IHHzd4V{e2WmIHHzJINmdGxidnnhZoltcXS7IHH0JFExKHWPIHHmeIVzKDR6IHjyd{BjgSC2conwZY4h[my3ZTDiZZNm\CCvaXPyc5Nkd3CrYzDhcoFtgXOrczDpckBxemW|ZX7j[UBw\iC|dYDldo95cWSnIHTpd412fGG|ZR?= M1zNRVIyPDN2NkCz
human PC3 cells MkmwVJJwdGmoZYLheIlwdiCjc4PhfS=> NXKye4xiOTBvMUCwJO69VQ>? MnWwOFghcA>? MkHRRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNiYYSgNVAhfG9iMUCwJJVOKGGodHXyJFQ5KGi{czDifUBp\W2xY4n0c41mfHKrYzDj[YxtKGOxdX70bY5oKG2ndHjv[C=> M4P2NFI{QDZ5MU[3
human A431 cells Ml7MSpVv[3Srb36gZZN{[Xl? NF25[lYyODBizszN MnH4NVIhcA>? M4jldXJm\HWldHnvckBw\iClbIXzeIVzcW6pIH;mJGdHWC2JUFmgbY4hdGmyaXSgdoFnfHNib3[gbJVu[W5iQUSzNUBk\WyuczDheEAyODBidV2gZYZ1\XJiMUKgbJJ{KGK7IHPvcoZw[2GuIH3pZ5Jwe2OxcHnjJIFv[Wy7c3nz MknwNlQ1PTZyMES=
human SKBR3 cells M2nHWWZ2dmO2aX;uJIF{e2G7 NGHKdVYzODEQvF2= NVX1OVVQOzBibXnudy=> MXLEc5dvemWpdXzheIlwdiCxZjDFdoJDOiCycn;0[YlvKGW6cILld5Nqd25iaX6gbJVu[W5iU1vCVlMh[2WubIOgbY4he2W{dX2g[pJm\SCvZXTpeY0h[XRiMkCwJJVOKGGodHXyJFMxKG2rboOgZpkhcW2vdX7v[ox2d3Knc3PlcoNmKHO2YXnubY5oNWKjc3XkJINwdm[xY3HsJI1q[3Kxc3PvdIlkKGGwYXz5d4l{ NHnWPJkzPDR3NkCwOC=>
human 293T cells NXyzNZJRTnWwY4Tpc44h[XO|YYm= NH:2cJg2OCEQvF2= M4\BXlEzKGh? M3\6OGlvcGmkaYTpc44hd2ZiRGnST|FCKGmwIHj1cYFvKDJ7M2SgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKEeOSUGgeJJidnOlcnnweIlwdiCjY4Tpeol1gSCjdDC1NEB2VSCjZoTldkAyOiCqcoOgZpkh\HWjbD3seYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> MVSyNlE2PDZ4NB?=

他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

お薦めの試験操作(参考用のみ)

溶解度 (25°C)

体外 Ethanol 83 mg/mL (181.07 mM) warming
DMSO 72 mg/mL warmed (157.07 mM)
Water 23 mg/mL warmed (50.17 mM)

* 溶解度測定はSelleck技術部門によって行われており、その他文献に示されている溶解度と差異がある可能性がありますが、同一ロットの生産工程で起きる正常な現象ですからご安心ください。

化学情報

分子量 458.37
化学式

C22H18O11

CAS No. 989-51-5
保管
in solvent
別名 EGCG

便利ツール

モル濃度計算器

モル濃度計算器

求めたい質量、体積または濃度を計算してください。

質量 (g) = 濃度 (mol/L) x 体積 (L) x 分子量 (g/mol)

モル濃度計算器方程式

  • 質量
    濃度
    体積
    分子量

*貯蔵液を準備するとき、常に、オンであるとわかる製品のバッチに特有の分子量を使って、を通してラベルとMSDS/COA(製品ページで利用可能な)。

希釈計算器

希釈計算器

貯蔵液を準備するために必要な希釈率を計算してください。Selleck希釈計算器は、以下の方程式に基づきます:

開始濃度 x 開始体積 = 最終濃度 x 最終体積

希釈の計算式

この方程式は、一般に略語を使われます:C1V1 = C2V2 ( 入力 出力 )

  • C1
    V1
    C2
    V2

常に貯蔵液を準備するとき、小びんラベルとMSDS/COA(オンラインで利用できる)で見つかる製品のバッチに特有の分子量を使ってください。

連続希釈計算器方程式

  • 連続希釈剤

  • 計算結果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量計算器

分子量计算器

そのモル質量と元素組成を計算するために、合成物の化学式を入力してください:

総分子量:g/mol

チップス: 化学式は大文字と小文字の区別ができます。C10H16N2O2 c10h16n2o2

モル濃度計算器

質量 濃度 体積 分子量

臨床試験

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03624556 Recruiting Down Syndrome|Fragile X Syndrome Parc de Salut Mar|Hospital Infantil Universitario Niño Jesús Madrid Spain|Instituto Hispalense de Pediatría Sevilla Spain|Hospital Universitario Marqués de Valdecilla|Institut Jerome Lejeune January 29 2018 Not Applicable
NCT03624556 Recruiting Down Syndrome|Fragile X Syndrome Parc de Salut Mar|Hospital Infantil Universitario Niño Jesús Madrid Spain|Instituto Hispalense de Pediatría Sevilla Spain|Hospital Universitario Marqués de Valdecilla|Institut Jerome Lejeune January 29 2018 Not Applicable
NCT02891538 Recruiting Colon Cancer The University of Texas Health Science Center at San Antonio January 31 2017 Early Phase 1
NCT02891538 Recruiting Colon Cancer The University of Texas Health Science Center at San Antonio January 31 2017 Early Phase 1
NCT02832271 Recruiting Endometriosis Chinese University of Hong Kong December 8 2016 Phase 2
NCT02832271 Recruiting Endometriosis Chinese University of Hong Kong December 8 2016 Phase 2

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

  • * 必須

Telomeraseシグナル伝達経路

相関Telomerase製品

Tags: (-)-Epigallocatechin Gallateを買う | (-)-Epigallocatechin Gallate ic50 | (-)-Epigallocatechin Gallate供給者 | (-)-Epigallocatechin Gallateを購入する | (-)-Epigallocatechin Gallate費用 | (-)-Epigallocatechin Gallate生産者 | オーダー(-)-Epigallocatechin Gallate | (-)-Epigallocatechin Gallate化学構造 | (-)-Epigallocatechin Gallate分子量 | (-)-Epigallocatechin Gallate代理店
×

大阪市内で「G20サミット」が開催されることに伴い、大阪府内で大規模な交通規制が行われる影響で、6月26日(水)から7月1日(月)までの間、下記地域へ出荷が行えなくなります。
対象地域
大阪府(全域)、兵庫県(芦屋市、尼崎市、伊丹市、西宮市)
上記地域より西の地域につきましては納期の遅延が予想されます。
また、国際便も遅延が予想されているため国内在庫がない製品の納期が一週間程度遅れる可能性がございます。
ご不便をおかけいたしますが、宜しくお願い申し上げます。

×
細胞株 試験類型 濃度 培養時間 溶剤類型 活性叙述 PMID